Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2020 - 12 - 01 save search
Westwater Appoints Karli Anderson to its Board of Directors
Published: 2018-09-27 (Crawled : 22:16) - globenewswire.com
WWR 4 | $0.431 6.42% 0.0% 150K
|
Non-Energy Minerals
| Email alert
Add to watchlist
Dynavax to Report First Quarter 2020 Financial Results and Host Conference Call on May 7, 2020
Published: 2020-04-23 (Crawled : 22:16) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M
|
Health Technology
|
| O: 4.44%
H: 0.57%
C: -3.68%
results
Dynavax Reports Interim Analysis of Ongoing Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodialysis
Published: 2020-04-28 (Crawled : 22:16) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M
|
Health Technology
|
| O: 2.86%
H: 5.81%
C: 4.8%
hemodialysis trial ongoing
Dynavax Announces First Quarter 2020 Financial Results
Published: 2020-05-07 (Crawled : 22:16) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M
|
Health Technology
|
| O: -3.3%
H: 3.42%
C: -3.19%
results
Dynavax Technologies Announces Proposed Public Offering of Common Stock
Published: 2020-05-21 (Crawled : 22:16) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M
|
Health Technology
|
| O: -4.59%
H: 5.74%
C: -5.0%
offering technology publication
Dynavax Technologies Announces Pricing of $70.0 Million Public Offering of Common Stock
Published: 2020-05-22 (Crawled : 22:16) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M
|
Health Technology
|
| O: -4.59%
H: 5.74%
C: -5.0%
offering
Dynavax Technologies Announces Closing of $80.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Published: 2020-05-27 (Crawled : 22:16) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M
|
Health Technology
|
| O: -1.82%
H: 1.65%
C: -0.21%
offering
Dynavax to Present at the William Blair 40th Annual Growth Stock Conference
Published: 2020-05-28 (Crawled : 22:16) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M
|
Health Technology
|
| O: 6.61%
H: 28.49%
C: 18.6%
growth
Dynavax Completes Enrollment of Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodialysis
Published: 2020-06-09 (Crawled : 22:16) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M
|
Health Technology
|
| O: 2.13%
H: 4.5%
C: -5.47%
hemodialysis trial enroll
Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Clover Biopharmaceuticals’ COVID-19 S-Trimer Vaccine Candidate with CpG 1018 Adjuvant
Published: 2020-06-19 (Crawled : 22:16) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M
|
Health Technology
|
| O: 5.38%
H: 9.42%
C: 1.16%
covid biopharma vaccine trial phase 3 phase 1 phase 2
Dynavax to Present at the H.C. Wainwright Virtual Fireside Chat Series
Published: 2020-06-22 (Crawled : 22:16) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M
|
Health Technology
|
| O: 2.22%
H: 2.54%
C: -0.37%
Dynavax and Times Pharmacy Announce Partnership to Offer HEPLISAV-B® Hepatitis B Vaccine to Customers Throughout Oahu, with a Focus on People with Diabetes
Published: 2020-07-10 (Crawled : 22:16) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M
|
Health Technology
| Email alert
Add to watchlist
diabetes partnership vaccine hepatitis
Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Medicago’s COVID-19 Vaccine Candidate with Dynavax’s CpG 1018 Adjuvant
Published: 2020-07-14 (Crawled : 22:16) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M
|
Health Technology
|
| O: 2.47%
H: 5.5%
C: 5.39%
covid vaccine trial phase 3 phase 1 phase 2
Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant
Published: 2020-07-16 (Crawled : 22:16) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M
|
Health Technology
|
| O: 3.16%
H: 1.8%
C: -1.72%
collaboration vaccine influenza announces collaboration
Dynavax Announces the Appointment of Two New Board Members
Published: 2020-07-21 (Crawled : 22:16) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M
|
Health Technology
|
| O: -2.15%
H: 3.2%
C: 1.5%
Dynavax and Medigen Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate
Published: 2020-07-23 (Crawled : 22:16) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M
|
Health Technology
|
| O: 0.99%
H: 5.17%
C: -1.27%
collaboration covid vaccine announces collaboration covid-19
Dynavax to Report Second Quarter 2020 Financial Results and Host Conference Call on August 6, 2020
Published: 2020-07-30 (Crawled : 22:16) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M
|
Health Technology
|
| O: -0.36%
H: 1.56%
C: -2.99%
results
TriSalus Life Sciences Acquires Dynavax’s SD-101 Oncology Program in Purchase Agreement for up to $250 million in Milestone Payments plus Royalties on Future Net Sales
Published: 2020-08-03 (Crawled : 22:16) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M
|
Health Technology
|
| O: 1.11%
H: 10.0%
C: 9.27%
sales life science royalties milestone
Dynavax Announces Second Quarter 2020 Financial Results
Published: 2020-08-06 (Crawled : 22:16) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M
|
Health Technology
|
| O: -7.6%
H: 1.03%
C: -4.54%
results
Dynavax Announces Grant to Scale up CpG 1018 Adjuvant Capacity to Support the Global COVID-19 Response
Published: 2020-08-13 (Crawled : 22:16) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M
|
Health Technology
|
| O: 1.74%
H: 0.14%
C: -2.85%
covid response granted grant
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.